Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Cyclophosphamide/fludarabine

Secondary poor graft function: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hama A, et al. Risk factors for secondary poor graft function after bone marrow transplantation in children with acquired aplastic anemia. Pediatric Transplantation 24: No. 7, Nov 2020. Available from: URL: http://doi.org/10.1111/petr.13828 Hama A, et al. Risk factors for secondary poor graft function after bone marrow transplantation in children with acquired aplastic anemia. Pediatric Transplantation 24: No. 7, Nov 2020. Available from: URL: http://​doi.​org/​10.​1111/​petr.​13828
Metadaten
Titel
Cyclophosphamide/fludarabine
Secondary poor graft function: 7 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88077-y

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Ruxolitinib

Case report

Tacrolimus

Case report

Thioctic-acid